Načítá se...
Immunohistochemical detection of the BRAF V600E mutant protein in colorectal neoplasms
Reliable assessment of the BRAF mutation status is becoming increasingly important in the clinical management of colorectal carcinomas (CRC). The aim of this study was to investigate the use of a recently developed mutation-specific antibody (VE1, SpringBio, Pleasanton, CA) to detect the BRAF V600E...
Uloženo v:
| Vydáno v: | Appl Immunohistochem Mol Morphol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4994705/ https://ncbi.nlm.nih.gov/pubmed/25517872 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PAI.0000000000000116 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|